PX1 Research supplies high-purity, USA-synthesized 5-Amino-1MQ engineered specifically for rigorous in vitro and preclinical laboratory investigations. As a selective nicotinamide N-methyltransferase (NNMT) inhibitor, this small molecule compound is widely evaluated for its capacity to preserve intracellular NAD+ levels, elevate mitochondrial output, and modulate adipose tissue metabolic pathways. Each lot undergoes comprehensive analytical verification, including reverse-phase HPLC, mass spectrometry, and endotoxin testing, ensuring batch-to-batch consistency for institutional research facilities.
PX1 Research supplies high-purity, USA-synthesized 5-Amino-1MQ engineered specifically for rigorous in vitro and preclinical laboratory investigations. As a selective nicotinamide N-methyltransferase (NNMT) inhibitor, this small molecule compound is widely evaluated for its capacity to preserve intracellular NAD+ levels, elevate mitochondrial output, and modulate adipose tissue metabolic pathways. Each lot undergoes comprehensive analytical verification, including reverse-phase HPLC, mass spectrometry, and endotoxin testing, ensuring batch-to-batch consistency for institutional research facilities.
When procuring chemical reagents for metabolic and enzymatic research, maintaining strict purity standards is essential to eliminate confounding experimental variables. Investigators seeking to purchase high-purity 5-Amino-1MQ 5mg vials require verified chemical integrity and precise lot-to-lot consistency. PX1 Research synthesizes 5-Amino-1MQ in GMP-compliant, USA-based facilities using automated solid-phase and solution-phase methodology, providing academic and corporate research entities with analytical-grade material.
Every batch of 5-Amino-1MQ undergoes comprehensive quality assurance protocols conducted by an independent ISO 17025-accredited laboratory. Verification includes high-performance liquid chromatography (HPLC) to establish purity thresholds exceeding 98.0%, alongside electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular weight and structural identity. By maintaining strict control over synthesis parameters and residual solvent removal, PX1 Research delivers 5-Amino-1MQ research-grade powder suitable for quantitative enzymatic assays, cell culture studies, and preclinical tissue models.
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme responsible for catalyzing the methylation of nicotinamide (NAM) using S-adenosylmethionine (SAM) as a methyl donor, yielding 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH). In metabolic tissues such as white adipose tissue (WAT) and hepatic parenchymal cells, elevated NNMT activity depletes the cellular pool of nicotinamide available for the NAD+ salvage pathway. 5-Amino-1MQ functions as a membrane-permeable, selective small-molecule inhibitor of NNMT, directly binding to the enzyme's catalytic site.
Preclinical studies suggest that competitive inhibition of NNMT by 5-Amino-1MQ prevents the irreversible clearance of nicotinamide. By halting the methyl transfer reaction, researchers can investigate how NNMT suppression influences cellular methyl donor availability, epigenetic histone methylation, and downstream metabolic flux. Detailed biochemical pathways and enzymatic assay data regarding NNMT regulation are indexed in the PX1 central research library.
Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme required for cellular redox reactions, oxidative phosphorylation, and sirtuin-mediated signaling pathways. Because NNMT consumes nicotinamide—the primary substrate for nicotinamide phosphoribosyltransferase (NAMPT) in the salvage pathway—high NNMT expression directly limits NAD+ biosynthesis. In vitro assays demonstrate that administration of 5-Amino-1MQ effectively blocks NNMT, shunting available nicotinamide back into the NAMPT enzymatic cascade and raising intracellular NAD+ concentration.
Restoring or augmenting cellular NAD+ pools through NNMT inhibition enhances the activity of NAD+-dependent enzymes, including SIRT1 and PARP-1. Researchers investigating cellular senescence, oxidative stress resilience, and energetic adaptation utilize 5-Amino-1MQ to model the metabolic consequences of elevated NAD+/NADH ratios. These biochemical shifts provide a controlled experimental framework for evaluating cellular lifespan, metabolic flexibility, and DNA repair mechanics in preclinical models.
Adipocytes and skeletal muscle cells treated with NNMT inhibitors exhibit marked changes in mitochondrial architecture and respiration kinetics. In vitro data indicate that 5-Amino-1MQ-mediated NNMT suppression stimulates mitochondrial biogenesis, increasing expression levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and nuclear respiratory factor 1 (NRF-1). Consequently, treated cell lines exhibit higher baseline oxygen consumption rates (OCR) and elevated basal ATP synthesis.
In animal models of metabolic dysregulation, high NNMT expression correlates with reduced lipid oxidation and expanded adipocyte volume. Preclinical research indicates that applying 5-Amino-1MQ supports fat-metabolism research by accelerating fatty acid beta-oxidation and promoting the browning of white adipose tissue. Researchers monitoring adipocyte differentiation and lipid droplet accumulation leverage this small molecule to dissect the precise energetic mechanisms underlying systemic metabolic expenditure.
To contextualize the operational profile of 5-Amino-1MQ, investigators frequently contrast its enzymatic mechanism with other metabolic research compounds that influence mitochondrial dynamics, growth hormone signaling, or lipolytic cascades. While 5-Amino-1MQ operates strictly as a small-molecule NNMT inhibitor to enhance the NAD+ salvage pathway, peptides such as the MOTS-c mitochondrial peptide function via mitochondrial-derived peptide pathways to modulate broad metabolic gene expression and glucose uptake. Similarly, researchers evaluating direct lipolytic fragments often pair or contrast 5-Amino-1MQ with the AOD-9604 fragment, which targets adipocyte beta-adrenergic receptors, or the hypothalamic growth hormone-releasing hormone analog Tesamorelin research peptide which acts upstream via the pituitary axis. Understanding these distinct molecular targets enables research facilities to select the precise biochemical agent required for their specific cell-signaling or metabolic assay design.
PX1 Research enforces rigorous quality control parameters for every chemical lot produced. Chemical identity and quantitative purity are validated using high-performance liquid chromatography coupled with ultraviolet spectroscopy (HPLC-UV) and electrospray mass spectrometry (ESI-MS). Each lot of 5-Amino-1MQ must achieve a minimum threshold of 98.0% chemical purity, with total impurities restricted to less than 2.0% and no single unidentified peak exceeding 0.5%.
Because biological assays—particularly primary cell cultures and tissue explants—are highly sensitive to bacterial contaminants, PX1 Research subjects all materials to Limulus Amebocyte Lysate (LAL) testing. Endotoxin levels are strictly maintained below 0.01 EU/mg. Institutional researchers can download lot-specific Certificates of Analysis (COAs) directly prior to procurement, confirming exact chromatographic profiles, molecular mass verification, and endotoxin test results.
5-Amino-1MQ (1-methyl-quinolin-1-ium-5-amine derivative) possesses specific solubility characteristics that dictate handling procedures in biological laboratory settings. As a synthetic quinolinium salt, the compound exhibits excellent solubility in polar organic solvents such as dimethyl sulfoxide (DMSO) and ethanol, as well as moderate solubility in sterile aqueous buffers including phosphate-buffered saline (PBS, pH 7.4).
For cell culture and enzymatic inhibition assays, initial stock solutions are typically prepared by dissolving 5-Amino-1MQ in sterile DMSO to reach concentrations of 10 mM to 50 mM. Once fully dissolved, stock solutions can be diluted into culture media or aqueous assay buffers, ensuring final DMSO concentrations remain below 0.1% (v/v) to avoid solvent-induced cytotoxicity. Reconstitution should be performed under a certified laminar flow hood utilizing sterile, pyrogen-free pipette tips and glass or polypropylene microcentrifuge tubes.
In lyophilized or solid powder form, 5-Amino-1MQ exhibits high chemical stability when protected from moisture and direct light exposure. For long-term storage (up to 24 months), the bulk material should be maintained at -20°C in a desiccated environment. Upon arrival at the research facility, vials should be allowed to equilibrate to room temperature before opening to prevent atmospheric condensation from accumulating on the hygroscopic powder.
Reconstituted liquid stock solutions in DMSO or aqueous buffers exhibit reduced long-term stability compared to the solid state. Aliquots of dissolved 5-Amino-1MQ should be stored at -80°C and subjected to minimal freeze-thaw cycles. Repeated temperature fluctuations accelerate chemical degradation and oxidation. Experimental protocols should account for aliquot volume to ensure single-use deployment during assay execution.
PX1 Research maintains inventory across state-of-the-art dispatch centers located in California and Arizona to support fast institutional procurement. All orders placed Monday through Friday prior to 3:00 PM EST are processed for same-day shipping. Reagents are packaged in ambient-controlled, impact-resistant containers equipped with temperature-monitoring indicators where applicable.
Academic laboratories, biotechnology firms, and contract research organizations (CROs) requiring multi-gram quantities or custom lot allocations can utilize the PX1 bulk institutional account program. Institutional accounts feature dedicated account support, streamlined procurement orders, and prior access to specific synthesis lots for long-term longitudinal studies.
What is the verified purity threshold for 5-Amino-1MQ supplied by PX1 Research?
Every lot of 5-Amino-1MQ supplied by PX1 Research is verified via high-performance liquid chromatography (HPLC) to meet or exceed 98.0% chemical purity, with structural identity confirmed by mass spectrometry (ESI-MS).
What primary enzymatic target does 5-Amino-1MQ inhibit in preclinical research?
5-Amino-1MQ acts as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that catalyzes the methylation of nicotinamide and regulates cellular NAD+ availability.
How does 5-Amino-1MQ influence intracellular NAD+ levels in cell culture models?
By inhibiting NNMT, 5-Amino-1MQ prevents the clearance of nicotinamide, allowing it to be recycled through the NAMPT salvage pathway to synthesize NAD+, thereby increasing intracellular NAD+ pools.
Are Certificates of Analysis (COA) available for individual lots of 5-Amino-1MQ?
Yes. Every batch of 5-Amino-1MQ includes a downloadable, lot-specific Certificate of Analysis detailing HPLC purity chromatograms, mass spectrometry results, and endotoxin assay data from an independent ISO 17025 accredited laboratory.
What solvents are recommended for reconstituting 5-Amino-1MQ for in vitro assays?
5-Amino-1MQ readily dissolves in dimethyl sulfoxide (DMSO) and sterile aqueous buffers such as PBS (pH 7.4). Preparation of high-concentration stock solutions in DMSO is recommended prior to diluting into culture media.
What are the endotoxin limits applied to PX1 Research small molecules?
PX1 Research subjects compounds to Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain below 0.01 EU/mg, minimizing cytotoxicity risks in biological assays.
How should lyophilized 5-Amino-1MQ be stored upon receipt?
Lyophilized powder should be stored at -20°C in a dry, dark environment. Reconstituted aliquots should be kept at -80°C and protected from repeated freeze-thaw cycles.
What are the shipping options and processing times for laboratory orders?
Orders placed Monday through Friday before 3:00 PM EST ship same-day from PX1 fulfillment centers in California and Arizona, utilizing expedited domestic and international carrier services.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.